-

Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the world’s leading provider of advanced ultrasound platforms for research and development, announced today the celebration of its 25th anniversary. Marking a quarter century of innovation, collaboration, and impact, this milestone highlights Verasonics’ longstanding commitment to empowering researchers, engineers, and commercial partners around the world with flexible, high-performance ultrasound technologies.

“From the beginning, our goal has been to give innovators the freedom to explore what’s possible with ultrasound.”

Share

“From the beginning, our goal has been to give innovators the freedom to explore what’s possible with ultrasound,” said Jon K. Daigle, CEO of Verasonics. “Our 25th anniversary is a celebration of the researchers, engineers, and partners who have pushed and expanded the boundaries of ultrasound innovation.”

Founded in 2001, Verasonics introduced a new paradigm in ultrasound by replacing hardware-based beamforming with a highly programmable software-based ultrasound platform. This approach provided researchers with direct control over system parameters, access to real-time raw channel data, and the ability to leverage rapid advances in computing power, unlocking new possibilities for experimentation, rapid prototyping, and commercialization. This vision has helped redefine ultrasound innovation worldwide.

Today, Verasonics systems are trusted by research and development teams in academia, commercial and government institutions around the world and have supported thousands of scientific publications across biomedical imaging, focused ultrasound therapy, photoacoustics, and nondestructive testing (NDT). Through its advanced, programmable ultrasound platforms and close collaboration with the global ultrasound community, Verasonics continues to help drive innovation across a wide range of applications.

As Verasonics celebrates 25 years of empowering ultrasound innovation, the company remains focused on the opportunities ahead. With advancements accelerating across imaging, therapy, and interdisciplinary applications, Verasonics will continue to equip customers with the powerful, flexible tools they need to shape what comes next. Verasonics thanks its customers and partners for being an essential part of this journey and looks forward to empowering the next generation of ultrasound discoveries and innovations.

About Verasonics, Inc.

Headquartered in Kirkland, Washington, USA, Verasonics is a privately held company founded in 2001. Verasonics, the leader in research ultrasound, empowers ultrasound innovation worldwide by providing flexible ultrasound platforms for research, development, and commercialization. Verasonics solutions are used across biomedical ultrasound, materials science, earth sciences, and acoustics to help accelerate innovation from concept to market. Verasonics also licenses its technology to companies for use in their commercial products.

Learn more by visiting the Verasonics website or following us on LinkedIn and X.

Contacts

Media Contact:
Verasonics, Inc.
James Schada
T: 425-439-7235
E: jamesschada@verasonics.com

Verasonics, Inc.


Release Summary
Verasonics celebrates 25 years of empowering ultrasound innovation and advancing research, development, and commercialization worldwide.
Release Versions

Contacts

Media Contact:
Verasonics, Inc.
James Schada
T: 425-439-7235
E: jamesschada@verasonics.com

Social Media Profiles
More News From Verasonics, Inc.

Verasonics Announces Vantage® NXT Platform Update Featuring Encoder Integration, Focused Ultrasound 2D/3D Software, New 8 MHz Matrix Array Transducer

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the leader in research ultrasound, today announced the release of a significant update for its Vantage NXT Research Ultrasound platform. The release introduces advanced hardware integration capabilities, expanded support for focused ultrasound (FUS) applications, enhanced real-time data synchronization tools, and compatibility with the new M8dV Matrix Array Transducer. The update is available immediately to all Vantage NXT customers. Key Featu...

Verasonics Announces Strategic Collaboration with ImFusion to Advance Ultrasound Innovations to the Clinic

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, the leader in advanced ultrasound research and development, is pleased to announce a new collaboration with ImFusion GmbH, a globally recognized provider of advanced medical image computing software. This collaboration brings together Verasonics’ industry-leading programmable Vantage® NXT Research Ultrasound Systems with ImFusion’s powerful software platform for real-time image reconstruction, 2D/3D visualization, and AI-powered workflows. Through t...

Verasonics Announces Enhancements to the Vantage® NXT Research Ultrasound Platform Designed to Further Improve Capabilities in Ultrasound Research and Product Development

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the leader in research ultrasound, today announced the release of new systems and features for the Vantage NXT Research Ultrasound Platform to advance ultrasound research and product development. New enhancements include Vantage NXT 32LE and 64 System configuration models and Acquisition SDK Option features. This release will be available to all Vantage NXT customers today. Enhancements to Vantage NXT in the Update include: Vantage NXT 32LE an...
Back to Newsroom